Innovator Spotlight: Chantal Vogels, Yale School of Public Health, developer of Saliva Test for NBA

12:55 PM - 1:25 PM (EDT), Monday, June 14, 2021
Search General Info
Search Education
Search Partnering Companies

Dr. Chantal Vogels is an Associate Research Scientist in the Department of Epidemiology of Microbial Diseases at the Yale School of Public Health. Her main research interest is in the emergence, spread, and evolution of arthropod-borne (arbo)viruses of public health importance.


Dr. Vogels received her Bachelor’s and Master’s degree in Biology at Wageningen University & Research, The Netherlands. She completed her PhD and first year of postdoctoral research in medical entomology and arbovirology at the Laboratory of Entomology, Wageningen University & Research. She then pursued her career as a Postdoctoral Fellow in the Grubaugh Lab at the Yale School of Public Health, where she is currently appointed as an Associate Research Scientist.


Since the start of the COVID-19 pandemic, Dr. Vogels has applied her expertise to the development of SARS-CoV-2 diagnostic assays and genomic surveillance. Together with her colleagues, she developed SalivaDirect, a simplified and flexible platform to enhance SARS-CoV-2 testing capacity. In addition, she led the development of a multiplex qPCR assay to enhance surveillance of SARS-CoV-2 variants of concern. Currently, she is dedicated to help increase SARS-CoV-2 genomic surveillance in Connecticut, while resuming her work on the evolution of arboviruses, such as Zika virus, West Nile virus, and dengue virus.

Moderator
photo
RAC, Senior Vice President, IVD Regulatory & Quality Consulting
Precision For Medicine
Speaker
photo
Associate Research Scientist, Department of Epidemiology of Microbial Diseases
Yale School of Public Health